We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 4,515 results
  1. The gut-liver axis: emerging mechanisms and therapeutic approaches for nonalcoholic fatty liver disease and type 2 diabetes mellitus

    Nonalcoholic fatty liver disease (NAFLD), more appropriately known as metabolic (dysfunction) associated fatty liver disease (MAFLD), a prevalent...

    Monika Bhardwaj, Papiya Mitra Mazumder in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 11 June 2024
  2. The gut-liver axis in hepatobiliary diseases

    Recent advances in the analysis of intestinal bacteria have led to reports of variations in intestinal bacterial levels among hepatobiliary diseases....

    Masataka Ichikawa, Haruka Okada, ... Takanori Kanai in Inflammation and Regeneration
    Article Open access 08 January 2024
  3. Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut–liver axis

    The close relationship between primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD) provides a good opportunity to comprehend...

    You Sun Kim, Edward H. Hurley, ... Sung** Ko in Experimental & Molecular Medicine
    Article Open access 18 July 2023
  4. Landscape of lipidomic metabolites in gut-liver axis of Sprague–Dawley rats after oral exposure to titanium dioxide nanoparticles

    Background

    The application of titanium dioxide nanoparticles (TiO 2 NPs) as food additives poses a risk of oral exposure that may lead to adverse...

    Zhangjian Chen, Shuo Han, ... Guang Jia in Particle and Fibre Toxicology
    Article Open access 03 August 2022
  5. The potential liver injury induced by metronidazole-provoked disturbance of gut microbiota: modulatory effect of turmeric supplementation

    It has been reported that the gut-liver axis and intestinal microbiome contribute crucially to different liver diseases. So, targeting this...

    Abdulaziz Qaid Ali, Deema Kamal Sabir, ... Lamiaa M. Shawky in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 26 June 2024
  6. Causal effects of gut microbiome on autoimmune liver disease: a two-sample Mendelian randomization study

    Background

    Epidemiological studies have indicated a potential link between the gut microbiome and autoimmune liver disease (AILD) such as autoimmune...

    Yugang Fu, Jiacheng Li, ... Yong Li in BMC Medical Genomics
    Article Open access 03 October 2023
  7. Synergistic anti-inflammatory effect of gut microbiota and lithocholic acid on liver fibrosis

    Background

    Bile acids can regulate liver disease progression by affecting the functions of gut microbiota and immune cells. As the most potent natural...

    Junwei Shao, Tiantian Ge, ... Zhi Chen in Inflammation Research
    Article 17 September 2022
  8. Urolithin C reveals anti-NAFLD potential via AMPK-ferroptosis axis and modulating gut microbiota

    The pharmacology of urolithin C (UroC) on non-alcoholic fatty liver disease (NAFLD) is largely undetermined. We sought to investigate the potential...

    **gyuan Xu, Hongyang Tian, ... Longbao Yang in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 01 May 2023
  9. Mulberry branch fiber improved lipid metabolism and egg yolk fatty acid composition of laying hens via the enterohepatic axis

    Background

    The utilization of mulberry branch fiber (MF), the largest by-product of the sericulture industry, is an important issue. Supplementation...

    Hong Hu, Anjian Li, ... Hongbin Pan in Microbiome
    Article Open access 12 April 2024
  10. Gut microbiome, liver immunology, and liver diseases

    The gut microbiota is a complex and plastic consortium of microorganisms that are intricately connected with human physiology. The liver is a central...

    Rui Wang, Ruqi Tang, ... Herbert Tilg in Cellular & Molecular Immunology
    Article 14 December 2020
  11. Gut-Derived Exosomes Induce Liver Injury After Intestinal Ischemia/Reperfusion by Promoting Hepatic Macrophage Polarization

    Liver injury induced by intestinal ischemia/reperfusion (I/R) is accompanied by the polarization of Kupffer cells, which are specialized macrophages...

    ** Zhao, **ao-Dong Chen, ... Cai Li in Inflammation
    Article 14 June 2022
  12. Gut Microbiome and Liver Cancer

    Liver cancer is a major cause of cancer-related death, and its incidence keeps rising. The liver is exposed to gut microbial products and metabolites...
    John C. McVey, Qianfei Zhang, ... Chi Ma in Inflammation, Infection, and Microbiome in Cancers
    Chapter 2021
  13. Coadministration of metformin prevents olanzapine-induced metabolic dysfunction and regulates the gut-liver axis in rats

    Objective

    Olanzapine is widely prescribed for patients with mental disorders; however, it may induce metabolic dysfunction. Metformin is an efficient...

    Chao Luo, Xu Wang, ... Zhao-Qian Liu in Psychopharmacology
    Article 23 October 2020
  14. Sialic acid exacerbates gut dysbiosis-associated mastitis through the microbiota-gut-mammary axis by fueling gut microbiota disruption

    Background

    Mastitis is one of the most severe diseases in humans and animals, especially on dairy farms. Mounting evidence indicates that...

    Caijun Zhao, **aoyu Hu, ... Yunhe Fu in Microbiome
    Article Open access 17 April 2023
  15. CCL5/CCR5 Axis in Cancer

    Inflammatory chemokines were primarily thought of in the past as essential "gatekeepers" of immunity and inflammation. Recent findings suggest that...
    Manzoor Ahmad Mir, Aamina Manzoor, Nusrat Jan in Cytokine and Chemokine Networks in Cancer
    Chapter 2023
  16. Gut microbiota-testis axis: FMT improves systemic and testicular micro-environment to increase semen quality in type 1 diabetes

    Background

    Clinical data suggest that male reproductive dysfunction especially infertility is a critical issue for type 1 diabetic patient (T1D)...

    Yanan Hao, Yanni Feng, ... Yong Zhao in Molecular Medicine
    Article Open access 25 April 2022
  17. Fine tuning the gut-liver-axis

    Maiju Myllys in Archives of Toxicology
    Article 05 September 2020
  18. The Microbiota-Gut-Liver Axis: Implications for the Pathophysiology of Liver Disease

    Interactions between the gut and the liver in relation to immunological responses and metabolic functions have been recognized as central to...
    Eamonn M. M. Quigley in Liver Immunology
    Chapter 2020
  19. Gut-Brain Axis Modulation of Metabolic Disorders: Exploring the Intertwined Neurohumoral Pathways and Therapeutic Prospects

    A significant rise in metabolic disorders, frequently brought on by lifestyle choices, is alarming. A wide range of preliminary studies indicates the...

    Diya Bhalla, Susha Dinesh, ... Gonchigar Jayanna Sathisha in Neurochemical Research
    Article 20 January 2024
  20. The interaction between the gut microbiota and dietary carbohydrates in nonalcoholic fatty liver disease

    Imbalance between fat production and consumption causes various metabolic disorders. Nonalcoholic fatty liver disease (NAFLD), one such pathology, is...

    Grace Park, Sunhee Jung, ... Cholsoon Jang in Experimental & Molecular Medicine
    Article Open access 20 May 2021
Did you find what you were looking for? Share feedback.